Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-04-13 @ 10:24 PM
Study NCT ID:
NCT06550895
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-05
First Post:
2024-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-09
First Submit QC Date:
None
Study First Post Date:
2024-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED